MYRIAD GENETICS INC — Director's Dealing 2018

Jul 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-07-11

Reporting Person: Capone Mark Christopher (President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-11	Common Stock	M	77654	$30.12	Acquired	409829	Direct
2018-07-11	Common Stock	S	77654	$41.0	Disposed	332175	Direct
2018-07-11	Common Stock	M	2346	$30.12	Acquired	334521	Direct
2018-07-11	Common Stock	S	2346	$41.0	Disposed	332175	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-11	Incentive Stock Option (right to buy)	$30.12	M	2346	Disposed	2019-02-18	Common Stock (2346)	Direct
2018-07-11	Non-Qualified Stock Option (right to buy)	$30.12	M	77654	Disposed	2019-02-18	Common Stock (77654)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.